TY  - CONF 
AU  - Sastre Moral, José Luis
PY  - 2014
SN  - 0390-6078
UR  - http://hdl.handle.net/20.500.11940/1107
LA  - eng
TI  - Very early molecular responses in the first two months of therapy are highly predictive of deep molecular responses at 18 months, in chronic myeloid leukemia patients treated upfront with nilotinib
VL  - 99
ER  -